Understanding the Current Rating
The Strong Sell rating assigned to Healthcare Global Enterprises Ltd indicates a cautious stance for investors. It suggests that the stock is expected to underperform relative to the broader market and peers in the hospital sector. This recommendation is based on a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals. Each of these factors contributes to the overall assessment of the company’s investment potential.
Quality Assessment
As of 16 April 2026, Healthcare Global Enterprises Ltd holds an average quality grade. This reflects moderate operational efficiency and profitability metrics. The company’s Return on Capital Employed (ROCE) stands at 6.65%, which is relatively low and indicates limited profitability generated from the total capital invested. Similarly, the Return on Equity (ROE) is 3.32%, signalling subdued returns for shareholders. These figures suggest that the company is currently struggling to generate strong returns on its investments and equity base, which weighs negatively on its quality score.
Valuation Perspective
Despite the challenges in operational performance, the stock’s valuation is considered attractive as of today. This implies that the current market price may offer some value relative to the company’s earnings and asset base. However, an attractive valuation alone does not offset the risks posed by other factors such as financial health and technical trends. Investors should interpret this valuation grade as a potential opportunity only if other fundamentals improve.
Financial Trend and Stability
The financial trend for Healthcare Global Enterprises Ltd is currently negative. The latest data shows a decline in profitability, with the company reporting a 21.87% decrease in Profit After Tax (PAT) over the last six months, amounting to ₹19.51 crores. The Earnings Per Share (EPS) for the latest quarter is negative at ₹-0.66, reflecting losses. Additionally, non-operating income constitutes 37.42% of Profit Before Tax (PBT), indicating reliance on non-core activities to support earnings. The company’s debt servicing capability is also a concern, with a high Debt to EBITDA ratio of 4.16 times, signalling elevated leverage and potential liquidity risks. Furthermore, 79.94% of promoter shares are pledged, which can exert downward pressure on the stock price in volatile markets. These factors collectively contribute to the negative financial grade and caution investors about the company’s near-term prospects.
Technical Analysis
The technical grade for the stock is bearish as of 16 April 2026. Recent price movements show mixed short-term gains but a clear downward trend over longer periods. The stock has gained 1.7% in the last day and 4.69% over the past week, but it has declined by 11.38% over three months and 19.17% over six months. Year-to-date, the stock is down 13.5%, and over the past year, it has fallen 3.36%. This pattern suggests that while there may be intermittent rallies, the overall momentum remains weak, reinforcing the cautious stance of the Strong Sell rating.
What This Means for Investors
For investors, the Strong Sell rating on Healthcare Global Enterprises Ltd signals a recommendation to avoid or exit positions in the stock at this time. The combination of average quality, attractive valuation, negative financial trends, and bearish technicals suggests that the company faces significant headwinds. The low profitability metrics and high leverage raise concerns about the company’s ability to generate sustainable returns and manage its debt obligations effectively. Additionally, the high percentage of pledged promoter shares adds an element of risk that could exacerbate price volatility in adverse market conditions.
Investors should closely monitor any changes in the company’s operational performance, debt levels, and market sentiment before considering exposure. The current rating reflects a comprehensive view of the risks and challenges facing Healthcare Global Enterprises Ltd as of 16 April 2026.
Fundamentals that don't lie! This Small Cap from Trading shows consistent growth and price strength over time. A reliable pick you can truly count on.
- - Strong fundamental track record
- - Consistent growth trajectory
- - Reliable price strength
Summary and Outlook
Healthcare Global Enterprises Ltd’s current Strong Sell rating reflects a cautious outlook grounded in its operational and financial challenges. While the stock’s valuation appears attractive, this is overshadowed by weak profitability, high leverage, and negative earnings trends. The technical indicators further reinforce the bearish sentiment, with the stock experiencing notable declines over recent months despite short-term gains.
Investors should consider these factors carefully and remain vigilant for any signs of improvement in the company’s fundamentals or market conditions. Until such positive developments occur, the Strong Sell rating advises prudence and suggests that the stock may continue to underperform relative to its peers and the broader market.
Key Metrics as of 16 April 2026
Market Capitalisation: Small Cap
Mojo Score: 28.0 (Strong Sell)
Quality Grade: Average
Valuation Grade: Attractive
Financial Grade: Negative
Technical Grade: Bearish
Debt to EBITDA Ratio: 4.16 times
ROCE: 6.65%
ROE: 3.32%
PAT Growth (Last 6 Months): -21.87%
EPS (Latest Quarter): ₹-0.66
Promoter Shares Pledged: 79.94%
Stock Returns Overview
1 Day: +1.70%
1 Week: +4.69%
1 Month: +3.70%
3 Months: -11.38%
6 Months: -19.17%
Year-to-Date: -13.50%
1 Year: -3.36%
These figures highlight the stock’s recent volatility and overall downward trajectory, underscoring the rationale behind the current rating.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
